Loading clinical trials...

COMPLETED

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain

An Observational, Retrospective Study to Describe the Extent of Adherence to the Spanish Society of Medical Oncology Algorithm for the Treatment of Hyponatraemia Secondary to SIADH in Oncology Patients in Spain (ALGA)

NCT02548845•Otsuka Pharmaceutical Europe Ltd

View on ClinicalTrials.gov

Summary

In 2014, the Spanish Sociedad Española de Oncología Médica (SEOM) algorithm for the treatment of hyponatraemia secondary to to syndrome of inappropriate antidiuretic hormone (SIADH) in oncology patients was developed. Since it is hypothesised that the adherence to the SEOM algorithm is not 100%, the current retrospective non-interventional study will investigate the perceived and actual adherence of participating centres to the SEOM algorithm and its impact on patient outcomes

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Provision of patient informed consent unless a) not required by local regulations, b) it would represent a non-reasonable effort or c) if the source patient is deceased or untraceable.
•Female and/or male oncology patients aged 18 years and over
•Patients who have experienced at least one occurrence of hyponatraemia secondary to the SIADH.

Exclusion Criteria

•A patient cannot take part in this study if participating in any clinical study in which the medicinal product aims to treat the causes or symptoms of hyponatraemia at the time of the hyponatraemia episode being documented in the current study.

Locations (4)

Castellon, Spain

Madrid, Spain

Santiago de Compostela, Spain

Seville, Spain

Key Dates

Start Date

December 1, 2015

Primary Completion Date

June 1, 2016

Completion Date

June 1, 2016

Last Updated

August 6, 2018

Enrollment

ACTUAL participants

Conditions

HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion

Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

NCT06408077

Hyponatremia

View study

COMPLETED

Retrospective Analysis of ECG Changes and Arrhythmias in Patients With Profound Hyponatremia

NCT07255833

Hyponatremia

View study

COMPLETEDNA

Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia

NCT03557957

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 6, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain

Inclusion Criteria

Exclusion Criteria

Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

Retrospective Analysis of ECG Changes and Arrhythmias in Patients With Profound Hyponatremia

Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia

Delirium Related to Proton Pump Inhibitors Use

Comparison of Isotonic Versus Hypotonic Fluids in Neonates for Maintenance Fluid Therapy After Surgery

Establishment of an Algorithm for a Clinical Classfication of Hypoosmolar Hyponatremia